Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
43 participants
OBSERVATIONAL
2019-02-22
2019-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prediction of Outcome by Echocardiography in Left Bundle Branch Block
NCT04293471
Fetal Cardiac Function Evaluation With aCMQ-Strain Fetal (STRAIN)
NCT03536000
Echocardiography in Cardiac Resynchronization Therapy (Echo-CRT)
NCT02986633
Left Ventricular Dysfunction in Critically Ill Patients
NCT03787810
Assessment of Left Ventricular Filling Pressure by Applying Artificial Intelligence Algorithms to Left Atrial Speckle-tracking Echocardiography
NCT05768698
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
two-dimensional speckle tracking
Analysis of myocardial left atrial strain using two-dimensional speckle tracking echocardiography.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No history of hypertension or mellitus diabetes.
Exclusion Criteria
* Athletes.
* Body mass index \< 16 or =\> 30 kg/m2.
* Previous treatment with cardiotoxic chemotherapy.
* Dilated left ventricle (telediastolic diameter index \> 30 mm/m2).
* Interventricular septal thickness =\> 12 mm.
* Dilated left atria (volume =\> 31 ml/m2).
* Systolic pulmonary pressure =\> 35 mmHg.
* Moderate or severe valvulopathy.
* Incomplete or suboptimal left atrial visualization.
* Frame rate \< 50 fps.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital de la Santa Creu i Sant Pau
Barcelona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IIBSP-STR-2018-111
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.